{"id":"W2956922241","doi":"10.1111/jdv.15793","title":"Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase‐3, randomized, placebo‐controlled trial","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"AbbVie","keywords":"Medicine; Adalimumab; Placebo; Psoriasis; Dermatology; Nail (fastener); Randomized controlled trial; Internal medicine; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001339934,0.0002987678,0.001917465,0.0001706496,0.0001766448,0.000008155796,0.0004038587,0.0004495774,0.0001319901],"category_scores_gemma":[0.0004357871,0.0001822329,0.0005177688,0.00006604939,0.0006319742,0.00009453779,0.0001522902,0.0004947186,0.00002062428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001488227,"about_ca_system_score_gemma":0.00005805739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004492199,"about_ca_topic_score_gemma":0.000001148397,"domain_scores_codex":[0.9943067,0.003788473,0.001232878,0.0002842984,0.00005720378,0.0003303769],"domain_scores_gemma":[0.9950352,0.003295669,0.001396967,0.0001708968,0.00005149146,0.00004971823],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9772249,0.0003075283,0.001328811,0.0000270355,0.003353196,0.00001289292,0.0003550363,0.000004691051,0.006194456,0.001608302,0.001263869,0.008319313],"study_design_scores_gemma":[0.9768475,0.0002998039,0.002325378,0.00006928183,0.001906366,0.001153918,0.00005717131,0.0000157614,0.00322208,0.001064529,0.0128585,0.000179675],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9790115,0.01425579,0.00009100747,0.002409799,0.001920216,0.001511983,0.0000548028,0.00001244078,0.0007325105],"genre_scores_gemma":[0.997267,0.001361905,0.00013018,0.000369884,0.0002446035,0.00001777453,0.00001197206,0.00002636486,0.0005702958],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01825557,"threshold_uncertainty_score":0.7431243,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01374117553980937,"score_gpt":0.2626512666596356,"score_spread":0.2489100911198263,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}